Hap Trading, LLC Glycomimetics Inc Transaction History
Hap Trading, LLC
- $872 Billion
- Q3 2024
A detailed history of Hap Trading, LLC transactions in Glycomimetics Inc stock. As of the latest transaction made, Hap Trading, LLC holds 36,200 shares of GLYC stock, worth $9,412. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,200Holding current value
$9,412% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding GLYC
# of Institutions
35Shares Held
17.7MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA9.54MShares$2.48 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$694,2540.0% of portfolio
-
Siren, L.L.C. New York, NY1.97MShares$510,9290.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny781KShares$203,0860.0% of portfolio
-
Black Rock Inc. New York, NY723KShares$188,0270.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $13.6M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...